Matches in Nanopublications for { ?s ?p ?o <http://rdf.disgenet.org/nanopublications.trig#NP73168.RAlZhWl5NNtjpV4w5x7P1wdmN1rDeR-q9IC7_Mn5-QeWU130_provenance>. }
Showing items 1 to 9 of
9
with 100 items per page.
- source_evidence_literature type ECO_0000212 NP73168.RAlZhWl5NNtjpV4w5x7P1wdmN1rDeR-q9IC7_Mn5-QeWU130_provenance.
- source_evidence_literature label "DisGeNET evidence - LITERATURE" NP73168.RAlZhWl5NNtjpV4w5x7P1wdmN1rDeR-q9IC7_Mn5-QeWU130_provenance.
- source_evidence_literature comment "Gene-disease associations inferred from text-mining the literature." NP73168.RAlZhWl5NNtjpV4w5x7P1wdmN1rDeR-q9IC7_Mn5-QeWU130_provenance.
- NP73168.RAlZhWl5NNtjpV4w5x7P1wdmN1rDeR-q9IC7_Mn5-QeWU130_assertion description "[both HTR2C and HTR2A gene polymorphisms seem to be associated with the occurrence of metabolic abnormalities in patients treated with olanzapine or clozapine.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP73168.RAlZhWl5NNtjpV4w5x7P1wdmN1rDeR-q9IC7_Mn5-QeWU130_provenance.
- NP73168.RAlZhWl5NNtjpV4w5x7P1wdmN1rDeR-q9IC7_Mn5-QeWU130_assertion evidence source_evidence_literature NP73168.RAlZhWl5NNtjpV4w5x7P1wdmN1rDeR-q9IC7_Mn5-QeWU130_provenance.
- NP73168.RAlZhWl5NNtjpV4w5x7P1wdmN1rDeR-q9IC7_Mn5-QeWU130_assertion SIO_000772 19142110 NP73168.RAlZhWl5NNtjpV4w5x7P1wdmN1rDeR-q9IC7_Mn5-QeWU130_provenance.
- NP73168.RAlZhWl5NNtjpV4w5x7P1wdmN1rDeR-q9IC7_Mn5-QeWU130_assertion wasDerivedFrom gad-20130706 NP73168.RAlZhWl5NNtjpV4w5x7P1wdmN1rDeR-q9IC7_Mn5-QeWU130_provenance.
- NP73168.RAlZhWl5NNtjpV4w5x7P1wdmN1rDeR-q9IC7_Mn5-QeWU130_assertion wasGeneratedBy ECO_0000203 NP73168.RAlZhWl5NNtjpV4w5x7P1wdmN1rDeR-q9IC7_Mn5-QeWU130_provenance.
- gad-20130706 importedOn "2013-07-06" NP73168.RAlZhWl5NNtjpV4w5x7P1wdmN1rDeR-q9IC7_Mn5-QeWU130_provenance.